Food & Health
PepsiCo (PEP.O) shares fell roughly 5% on Thursday after the snack-and-beverage giant posted second-quarter core earnings per share of $2.20 – slightly below consensus – as North American food sales dropped 2% and the company flagged higher commodity costs ahead.
For long-horizon investors,...
Roche (RHHBY) said its experimental lung-cancer drug divarasib beat existing therapies on both overall...
Genmab (GMAB) shares jumped 3.5% in after-hours trading Monday after the company and partner AbbVie said...
Pfizer (PFE) has been dismissed as a defendant in the sweeping multi-state generic drug price-fixing...
Europe’s drug advisory committee recommended approval of Sanofi’s (SNY) Cenrifki for non-relapsing...
AbbVie (ABBV) is nearing a $10.9 billion all-cash deal for Apogee Therapeutics (APGE), acquiring a long-acting...
GSK plc (GSK.L / GSK) secured U.S. FDA approval for gepotidacin (Blujepa), a first-in-class oral antibiotic...
Trending
CATEGORIES
Categories
SIGNUP TO OUR NEWSLETTER
Subscribe
Get breaking market insights directly to your inbox